Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury

Area of Science:

• Pediatric critical care medicine
• Infectious disease epidemiology
• Neurotrauma research

Background:

• Ventilator-associated pneumonia (VAP) is a significant complication in intubated pediatric patients with moderate-to-severe traumatic brain injury (TBI).
• Limited data exists on the specific epidemiology, risk factors, and causative microorganisms of VAP in this vulnerable population.
• Understanding these factors is crucial for developing targeted prevention and treatment strategies.

Purpose of the Study:

• To investigate the incidence, risk factors, microbiology, and clinical outcomes of VAP in pediatric patients with moderate-to-severe TBI.
• To identify specific treatments or patient characteristics associated with an increased risk of developing VAP.
• To inform clinical practice regarding the early management of VAP in this cohort.

Main Methods:

• Retrospective cohort review of 119 pediatric patients with moderate-to-severe TBI.
• Identification of VAP cases through positive protected bronchial brush specimens.
• Multivariable analysis to determine independent risk factors for VAP development.

Main Results:

• VAP was identified in 42 patients (35%).
• Barbiturate coma (HR 3.2), neuromuscular blockade (NMBA; HR 3.4), and cooling blankets (HR 2.4) were independently associated with increased VAP risk.
• Common pathogens included Methicillin-sensitive Staphylococcus aureus (34%), Haemophilus influenzae (22%), and Streptococcus pneumoniae (15%). Most VAP occurred early (before Day 4).
• VAP was associated with longer ICU and hospital stays and increased need for chronic care, but not mortality.

Conclusions:

• VAP is a frequent complication in pediatric TBI patients, often occurring early in the hospital course.
• Specific intensive care interventions, including barbiturate coma, NMBA, and cooling blankets, are significant risk factors for VAP.
• Early empiric antibiotic therapy for high-risk patients may help reduce morbidity associated with VAP in pediatric TBI.